Restoration of Consciousness With Ultrasonic Deep Brain Stimulation During Anesthetic Sedation

NCT07221539 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2025-10-28

No results posted yet for this study

Summary

The purpose of this study is to see if mental functions take place during different levels of anesthesia using two commonly used drug (propofol and dexmedetomidine) and will include low-intensity focused ultrasound pulsation (LIFUP) to stimulate specific areas of the brain while undergoing functional Magnetic Resonance Imaging (fMRI or "brain imaging"), which shows areas in the brain involved in thinking at different depths of anesthesia. That is, ultrasound is being used to stimulate the brain and multiple pictures will be taken of the brain.

As a result of this study, we expect to gain a deeper understanding of mental function during different levels of anesthesia, and to evaluate if the use of ultrasonic brain stimulation accelerates return to consciousness.

Conditions

  • Mental Function

Interventions

PROCEDURE

Propofol for fMRI

Propofol infusion

PROCEDURE

Dexmedetomidine for fMRI

Dexmedetomidine infusion

DEVICE

Dorsolateral prefrontal cortex (DLPFC) pulsation

BXPulsar 1002 low-intensity focused ultrasound pulsation (LIFUP) on the DFPFC

DEVICE

Anterior insular cortex (AIC) pulsation

BXPulsar 1002 LIFUP to AIC

DEVICE

Central thalamus (CT) pulsation

BXPulsar 1002 LIFUP to CT

Sponsors & Collaborators

Principal Investigators

  • Zirui Huang · University of Michigan

  • Anthony Hudetz · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-24
Primary Completion
2030-09-30
Completion
2030-10-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07221539 on ClinicalTrials.gov